Literature DB >> 19234196

Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8.

Jean-François Marquis1, Ronald LaCourse, Lynn Ryan, Robert J North, Philippe Gros.   

Abstract

The interferon regulatory factor (IRF) family member IRF-8 participates in IFN-gamma-dependent transcriptional activation of genes containing in their promoter regions IFN-stimulated response element or IFN-gamma activation site elements. To test the role of IRF-8 in host defenses against tuberculosis, BXH-2 mice, which bear a defective IRF-8(R294C) allele, were challenged with low doses of virulent Mycobacterium tuberculosis via the i.v. and aerosol routes. BXH-2 mice were found to be extremely susceptible to M. tuberculosis, as demonstrated by rapid and uncontrolled microbial replication in spleen, liver, and lungs leading to very early death. The BXH-2 defect was expressed very early (10 days postinfection) as uncontrolled intracellular pathogen replication in NOS2-expressing lung macrophages, impaired granuloma formation, rapid dissemination of the infection to distant sites, and rapid necrosis of infected tissues. There was complete absence of IL-12p40 induction, severely reduced IFN-gamma production, and impaired T cell priming in the lungs of infected BXH-2, highlighting the critical role of IRF-8 in this process. Collectively, these results identify IRF-8 as a critical regulator of host defenses against tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234196      PMCID: PMC4307599          DOI: 10.4049/jimmunol.0800680

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

Review 1.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells.

Authors:  Hideki Tsujimura; Tomohiko Tamura; Keiko Ozato
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

3.  Ipr1 gene mediates innate immunity to tuberculosis.

Authors:  Hui Pan; Bo-Shiun Yan; Mauricio Rojas; Yuriy V Shebzukhov; Hongwei Zhou; Lester Kobzik; Darren E Higgins; Mark J Daly; Barry R Bloom; Igor Kramnik
Journal:  Nature       Date:  2005-04-07       Impact factor: 49.962

4.  Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production.

Authors:  Carl G Feng; Dragana Jankovic; Marika Kullberg; Allen Cheever; Charles A Scanga; Sara Hieny; Patricia Caspar; George S Yap; Alan Sher
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

5.  Identification of IRF-8 and IRF-1 target genes in activated macrophages.

Authors:  Natalie Dror; Michal Alter-Koltunoff; Aviva Azriel; Ninette Amariglio; Jasmine Jacob-Hirsch; Sharon Zeligson; Avigail Morgenstern; Tomohiko Tamura; Hansjörg Hauser; Gideon Rechavi; Keiko Ozato; Ben-Zion Levi
Journal:  Mol Immunol       Date:  2006-04-04       Impact factor: 4.407

6.  Transplacental transmission of a leukemogenic murine leukemia virus.

Authors:  H G Bedigian; L A Shepel; P C Hoppe
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

7.  STAT1 knockout mice are highly susceptible to pulmonary mycobacterial infection.

Authors:  Isamu Sugawara; Hiroyuki Yamada; Satoru Mizuno
Journal:  Tohoku J Exp Med       Date:  2004-01       Impact factor: 1.848

8.  Interferon regulatory factor 1 in mycobacterial infection.

Authors:  Hiroyuki Yamada; Satoru Mizuno; Isamu Sugawara
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

9.  IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; J Sypek; S Wolf; B R Bloom
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

Review 10.  The interferon regulatory factor family in host defense: mechanism of action.

Authors:  Keiko Ozato; Prafullakumar Tailor; Toru Kubota
Journal:  J Biol Chem       Date:  2007-05-14       Impact factor: 5.157

View more
  19 in total

1.  Inactivating Mutation in IRF8 Promotes Osteoclast Transcriptional Programs and Increases Susceptibility to Tooth Root Resorption.

Authors:  Vivek Thumbigere-Math; Brian L Foster; Mahesh Bachu; Hiroaki Yoshii; Stephen R Brooks; Alyssa Coulter; Michael B Chavez; Sumihito Togi; Anthony L Neely; Zuoming Deng; Kim C Mansky; Keiko Ozato; Martha J Somerman
Journal:  J Bone Miner Res       Date:  2019-03-06       Impact factor: 6.741

Review 2.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

3.  A novel form of human STAT1 deficiency impairing early but not late responses to interferons.

Authors:  Xiao-Fei Kong; Michael Ciancanelli; Sami Al-Hajjar; Laia Alsina; Timothy Zumwalt; Jacinta Bustamante; Jacqueline Feinberg; Magali Audry; Carolina Prando; Vanessa Bryant; Alexandra Kreins; Dusan Bogunovic; Rabih Halwani; Xin-Xin Zhang; Laurent Abel; Damien Chaussabel; Saleh Al-Muhsen; Jean-Laurent Casanova; Stéphanie Boisson-Dupuis
Journal:  Blood       Date:  2010-09-14       Impact factor: 22.113

4.  Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-γ signaling.

Authors:  Katherine C MacNamara; Kwadwo Oduro; Olga Martin; Derek D Jones; Maura McLaughlin; Kyunghee Choi; Dori L Borjesson; Gary M Winslow
Journal:  J Immunol       Date:  2010-12-13       Impact factor: 5.422

5.  Are mouse models of human mycobacterial diseases relevant? Genetics says: 'yes!'.

Authors:  Alexander S Apt
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

6.  IRF8 mutations and human dendritic-cell immunodeficiency.

Authors:  Sophie Hambleton; Sandra Salem; Jacinta Bustamante; Venetia Bigley; Stéphanie Boisson-Dupuis; Joana Azevedo; Anny Fortin; Muzlifah Haniffa; Lourdes Ceron-Gutierrez; Chris M Bacon; Geetha Menon; Céline Trouillet; David McDonald; Peter Carey; Florent Ginhoux; Laia Alsina; Timothy J Zumwalt; Xiao-Fei Kong; Dinakantha Kumararatne; Karina Butler; Marjorie Hubeau; Jacqueline Feinberg; Saleh Al-Muhsen; Andrew Cant; Laurent Abel; Damien Chaussabel; Rainer Doffinger; Eduardo Talesnik; Anete Grumach; Alberto Duarte; Katia Abarca; Dewton Moraes-Vasconcelos; David Burk; Albert Berghuis; Frédéric Geissmann; Matthew Collin; Jean-Laurent Casanova; Philippe Gros
Journal:  N Engl J Med       Date:  2011-04-27       Impact factor: 91.245

7.  Tagging single nucleotide polymorphisms in the IRF1 and IRF8 genes and tuberculosis susceptibility.

Authors:  Shiping Ding; Tao Jiang; Jianqin He; Beibei Qin; Shuangyan Lin; Lanjuan Li
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

8.  Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis.

Authors:  Jean-François Marquis; Oxana Kapoustina; David Langlais; Rebecca Ruddy; Catherine Rosa Dufour; Bae-Hoon Kim; John D MacMicking; Vincent Giguère; Philippe Gros
Journal:  PLoS Genet       Date:  2011-06-23       Impact factor: 5.917

9.  Compensatory dendritic cell development mediated by BATF-IRF interactions.

Authors:  Roxane Tussiwand; Wan-Ling Lee; Theresa L Murphy; Mona Mashayekhi; Wumesh KC; Jörn C Albring; Ansuman T Satpathy; Jeffrey A Rotondo; Brian T Edelson; Nicole M Kretzer; Xiaodi Wu; Leslie A Weiss; Elke Glasmacher; Peng Li; Wei Liao; Michael Behnke; Samuel S K Lam; Cora T Aurthur; Warren J Leonard; Harinder Singh; Christina L Stallings; L David Sibley; Robert D Schreiber; Kenneth M Murphy
Journal:  Nature       Date:  2012-09-19       Impact factor: 49.962

10.  Interferon regulatory factor 8-deficiency determines massive neutrophil recruitment but T cell defect in fast growing granulomas during tuberculosis.

Authors:  Stefano Rocca; Giovanna Schiavoni; Michela Sali; Antonio Giovanni Anfossi; Laura Abalsamo; Ivana Palucci; Fabrizio Mattei; Massimo Sanchez; Anna Giagu; Elisabetta Antuofermo; Giovanni Fadda; Filippo Belardelli; Giovanni Delogu; Lucia Gabriele
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.